These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 31083442)

  • 21. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
    Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
    Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular contributions to Alzheimer's disease.
    Eisenmenger LB; Peret A; Famakin BM; Spahic A; Roberts GS; Bockholt JH; Johnson KM; Paulsen JS
    Transl Res; 2023 Apr; 254():41-53. PubMed ID: 36529160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
    Boese AC; Hamblin MH; Lee JP
    Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
    Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
    Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.
    Grossmann K
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
    Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
    Fisher RA; Miners JS; Love S
    Brain Pathol; 2022 Nov; 32(6):e13061. PubMed ID: 35289012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Traumatic brain injury as risk factor of Alzheimer's disease and possibilities of pathogenetic therapy].
    Litvinenko IV; Naumov KM; Lobzin VY; Emelin AY; Dynin PS; Kolmakova KA; Nikishin VO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):45-54. PubMed ID: 38261283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia.
    Uemura MT; Maki T; Ihara M; Lee VMY; Trojanowski JQ
    Front Aging Neurosci; 2020; 12():80. PubMed ID: 32317958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
    Zlokovic BV
    Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán R; Sone JY; Fossati S
    J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.
    Janelidze S; Hertze J; Nägga K; Nilsson K; Nilsson C; ; Wennström M; van Westen D; Blennow K; Zetterberg H; Hansson O
    Neurobiol Aging; 2017 Mar; 51():104-112. PubMed ID: 28061383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.
    Di Marco LY; Venneri A; Farkas E; Evans PC; Marzo A; Frangi AF
    Neurobiol Dis; 2015 Oct; 82():593-606. PubMed ID: 26311408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?
    Kelleher RJ; Soiza RL
    Am J Cardiovasc Dis; 2013 Nov; 3(4):197-226. PubMed ID: 24224133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease.
    Canobbio I; Abubaker AA; Visconte C; Torti M; Pula G
    Front Cell Neurosci; 2015; 9():65. PubMed ID: 25784858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease.
    Yue Q; Hoi MPM
    Neural Regen Res; 2023 Sep; 18(9):1890-1902. PubMed ID: 36926705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
    Sagare AP; Bell RD; Zlokovic BV
    J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The blood-brain barrier in Alzheimer's disease.
    Zenaro E; Piacentino G; Constantin G
    Neurobiol Dis; 2017 Nov; 107():41-56. PubMed ID: 27425887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.